US Broker Ratings

Mettler-Toledo International (MTD) Stock Analysis: Navigating a Potential -8.66% Downside in the Diagnostics & Research Sector

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the healthcare sector specializing in diagnostics and research, commands a market capitalization of $33.47 billion. Headquartered in..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Powerhouse with a 110% Upside Potential

Investors with an eye on the healthcare sector may find Insmed Incorporated (NASDAQ: INSM) a compelling opportunity. As a biotechnology firm specializing in therapies for serious..

Penumbra, Inc. (PEN) Stock Analysis: Exploring the 11.76% Upside Potential in the Medical Devices Sector

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, specifically within the medical devices industry, stands out with a robust market capitalization of $12.78..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating a Potential 11.44% Upside

As a titan in the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) has long been a critical player in the diagnostics and research industry, offering..

ResMed Inc. (RMD) Stock Analysis: Navigating Flat Terrain with Strong Fundamentals

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, specifically within the medical instruments and supplies industry, is a prominent player in the digital health..

Genmab A/S (GMAB) Stock Analysis: A Biotech Powerhouse with Strong Buy Ratings and 7.6% Upside Potential

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is capturing the attention of investors with its impressive market presence and innovative strides in..

Baxter International Inc. (BAX)

⚠️ No article content returned.

..

Cencora, Inc. (COR)

⚠️ No article content returned.

..

Natera, Inc. (NTRA) Stock Analysis: Riding a Wave of 37.7% Revenue Growth and Strong Buy Ratings

Natera, Inc. (NTRA), a prominent player in the healthcare sector specializing in diagnostics and research, has been capturing investor attention with its significant revenue growth and..

argenx SE (ARGX) Stock Analysis: Exploring Its 30.93% Potential Upside and Growth Dynamics

Investors with an eye on the biotechnology sector should take a closer look at argenx SE (NASDAQ: ARGX), a Netherlands-based biopharmaceutical company making significant strides in..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 13.83% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a prominent name in the healthcare sector specializing in medical devices, is capturing investor attention with a market capitalization of $51.29..

Zimmer Biomet Holdings, Inc. (ZBH) Investor Outlook: Exploring an 8.47% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Growth in the Biotech Sector with a 2.37% Upside

Royalty Pharma plc (NASDAQ: RPRX) presents a unique investment opportunity within the biotechnology sector. With a market capitalization of $36.9 billion, this New York-based company operates..

Quest Diagnostics (DGX) Stock Analysis: Healthcare Giant with 5.31% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a stalwart in the healthcare sector, holds a commanding position within the Diagnostics & Research industry. Headquartered in Secaucus, New Jersey,..

Zoetis Inc. (ZTS) Stock Report: Exploring a 14.77% Potential Upside Amidst a Robust Dividend Yield

Investors looking for opportunities in the healthcare sector may want to keep an eye on Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry...

Novo Nordisk A/S (NVO) Stock Analysis: Evaluating Growth Potential Amid Healthcare Innovations

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture the attention of investors seeking robust growth opportunities in the pharmaceutical industry...

McKesson Corporation (MCK) Stock Report: Analyzing Its $116.68 Billion Market Cap and Growth Potential

As one of the stalwarts in the healthcare sector, McKesson Corporation (NYSE: MCK) continues to capture investor attention with its robust market presence and a market..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: Is a 64% Upside Within Reach for Investors?

Alnylam Pharmaceuticals, Inc. (ALNY), a key player in the biotechnology sector, is drawing attention from investors with its robust pipeline and promising financial metrics. Although the..

BioNTech SE (BNTX) Stock Analysis: Navigating the 32% Potential Upside in the Biotech Sector

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has garnered considerable attention from investors with its pioneering work in immunotherapies. Headquartered in Mainz,..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating Growth and Valuation Metrics Amid High Market Cap

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the U.S. healthcare sector, boasting a significant market capitalization of $104.05 billion. This healthcare giant,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds